Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Trojsi

Showing results (111-120 of 131) with videos related to

Pageof 14
Sort By:
Biomedicines|May 28, 2022
Repetitive Transcranial Magnetic Stimulation (rTMS) of Dorsolateral Prefrontal Cortex May Influence Semantic Fluency and Functional Connectivity in Fronto-Parietal Network in Mild Cognitive Impairment (MCI)Sabrina Esposito, Francesca Trojsi, Giovanni Cirillo, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 25, 2016
Targeting Extracellular Cyclophilin A Reduces Neuroinflammation and Extends Survival in a Mouse Model of Amyotrophic Lateral SclerosisLaura Pasetto, Silvia Pozzi, Mariachiara Castelnovo, et al.
Journal of Clinical Medicine|April 3, 2021
Physical Exercise Moderates the Effects of Disability on Depression in People with Multiple Sclerosis during the COVID-19 OutbreakAntonio Carotenuto, Cristiano Scandurra, Teresa Costabile, et al.
International Journal of Molecular Sciences|May 27, 2026
Longitudinal CSF and Serum Biomarker Dynamics in Tofersen-Treated <i>SOD1</i>-ALS: A Real-World Multicentre Cohort StudyAndrea Giordano, Jessica Mandrioli, Federica Cerri, et al.
Journal of Clinical Medicine|April 23, 2022
Prognostic Markers of Ocrelizumab Effectiveness in Multiple Sclerosis: A Real World Observational Multicenter StudyRoberta Lanzillo, Antonio Carotenuto, Elisabetta Signoriello, et al.
Journal of Neurology|October 26, 2016
Factors predicting survival in ALS: a multicenter Italian studyAndrea Calvo, Cristina Moglia, Christian Lunetta, et al.
Brain Communications|September 18, 2024
Colchicine treatment in amyotrophic lateral sclerosis: safety, biological and clinical effects in a randomized clinical trialGiulia Gianferrari, Riccardo Cuoghi Costantini, Valeria Crippa, et al.
Frontiers in Neuroscience|June 4, 2019
Comparative Analysis of <i>C9orf72</i> and Sporadic Disease in a Large Multicenter ALS Population: The Effect of Male Sex on Survival of <i>C9orf72</i> Positive PatientsFrancesca Trojsi, Mattia Siciliano, Cinzia Femiano, et al.
Journal of Neurology|September 16, 2017
Comorbidity of dementia with amyotrophic lateral sclerosis (ALS): insights from a large multicenter Italian cohortFrancesca Trojsi, Mattia Siciliano, Cinzia Femiano, et al.
Journal of Neurology|June 28, 2023
Retrospective observational study on the use of acetyl-L-carnitine in ALSSerena Sassi, Elisa Bianchi, Luca Diamanti, et al.
Pageof 14

Showing results (111-120 of 131) with videos related to

Sort By:
Pageof 14
Biomedicines|May 28, 2022
Repetitive Transcranial Magnetic Stimulation (rTMS) of Dorsolateral Prefrontal Cortex May Influence Semantic Fluency and Functional Connectivity in Fronto-Parietal Network in Mild Cognitive Impairment (MCI)Sabrina Esposito, Francesca Trojsi, Giovanni Cirillo, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 25, 2016
Targeting Extracellular Cyclophilin A Reduces Neuroinflammation and Extends Survival in a Mouse Model of Amyotrophic Lateral SclerosisLaura Pasetto, Silvia Pozzi, Mariachiara Castelnovo, et al.
Journal of Clinical Medicine|April 3, 2021
Physical Exercise Moderates the Effects of Disability on Depression in People with Multiple Sclerosis during the COVID-19 OutbreakAntonio Carotenuto, Cristiano Scandurra, Teresa Costabile, et al.
International Journal of Molecular Sciences|May 27, 2026
Longitudinal CSF and Serum Biomarker Dynamics in Tofersen-Treated <i>SOD1</i>-ALS: A Real-World Multicentre Cohort StudyAndrea Giordano, Jessica Mandrioli, Federica Cerri, et al.
Journal of Clinical Medicine|April 23, 2022
Prognostic Markers of Ocrelizumab Effectiveness in Multiple Sclerosis: A Real World Observational Multicenter StudyRoberta Lanzillo, Antonio Carotenuto, Elisabetta Signoriello, et al.
Journal of Neurology|October 26, 2016
Factors predicting survival in ALS: a multicenter Italian studyAndrea Calvo, Cristina Moglia, Christian Lunetta, et al.
Brain Communications|September 18, 2024
Colchicine treatment in amyotrophic lateral sclerosis: safety, biological and clinical effects in a randomized clinical trialGiulia Gianferrari, Riccardo Cuoghi Costantini, Valeria Crippa, et al.
Frontiers in Neuroscience|June 4, 2019
Comparative Analysis of <i>C9orf72</i> and Sporadic Disease in a Large Multicenter ALS Population: The Effect of Male Sex on Survival of <i>C9orf72</i> Positive PatientsFrancesca Trojsi, Mattia Siciliano, Cinzia Femiano, et al.
Journal of Neurology|September 16, 2017
Comorbidity of dementia with amyotrophic lateral sclerosis (ALS): insights from a large multicenter Italian cohortFrancesca Trojsi, Mattia Siciliano, Cinzia Femiano, et al.
Journal of Neurology|June 28, 2023
Retrospective observational study on the use of acetyl-L-carnitine in ALSSerena Sassi, Elisa Bianchi, Luca Diamanti, et al.
Pageof 14